Legend Biotech Corp Stock In The News
| LEGN Stock | USD 38.05 0.19 0.50% |
Our overall analysis of Legend Biotech's news coverage and content from conventional and social sources shows investors' bearish mood towards Legend Biotech Corp. The specific impact of Legend Biotech news on its stock price will depend on a range of factors, including the nature and significance of the news report and investors' perceptions of Legend Biotech's overall financial health and prospects. It also depends on the type and quality of a news publisher.
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using Legend Biotech headlines in addition to utilizing other, more conventional financial analysis modules. Check out Legend Biotech Backtesting and Legend Biotech Hype Analysis.
Legend |
Legend Biotech Today Top News and Investor Outlook
Legend Biotech Corp Past News Timeline
Popular news outlets such as MarketWatch, Bloomberg, or Reuters provide Legend and other traded companies coverage with news coverage. We help investors stay connected with Legend headlines for the 13th of March 2025 to make an informed investment decision based on correlating the impacts of news items on Legend Stock performance. Please note that trading solely based on the Legend Biotech Corp hype is not for everyone as timely availability and quick action are needed to avoid losses.
Legend Biotech stock price changes are notoriously difficult to predict based exclusively on its news coverage or social hype. Still, the Legend earnings-per-share ratio is a good starting point for gauging a company's future prospects. If a firm's EPS rises and meets or even beats consensus forecasts, its shares stand to increase. However, some very sophisticated investors can spot management manipulation of EPS through actions such as buybacks.
Far too much social signal, news, headlines, and media speculation about Legend Biotech that are available to investors today. That information is available publicly through Legend media outlets and privately through word of mouth or via Legend internal channels. However, regardless of the origin, that massive amount of Legend data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Legend Biotech news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Legend Biotech relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Legend Biotech's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Legend Biotech alpha.
Legend Largest EPS Surprises
Earnings surprises can significantly impact Legend Biotech's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2021-05-18 | 2021-03-31 | -0.35 | -0.3 | 0.05 | 14 | ||
2022-12-14 | 2022-09-30 | -0.31 | -0.37 | -0.06 | 19 | ||
2021-03-18 | 2020-12-31 | -0.28 | -0.22 | 0.06 | 21 | ||
2021-11-16 | 2021-09-30 | -0.35 | -0.43 | -0.08 | 22 | ||
2023-05-18 | 2023-03-31 | -0.78 | -0.68 | 0.1 | 12 | ||
2022-03-18 | 2021-12-31 | -0.41 | -0.3 | 0.11 | 26 |
Legend Biotech Stock Latest Headlines
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using conventional financial analysis. Below is the latest headlines and news related to Legend Biotech Corp Stock. Current markets are slightly bearish. About 51% of major world exchanges and indexes are down. See today's market update for more information.
12th of March 2025
Legend Biotech Given Neutral Rating at Guggenheim at thelincolnianonline.com
5th of March 2025
Is Legend Biotech Gaining or Losing Market Support - Benzinga at news.google.com
25th of February 2025
Legend Biotech to Host Investor Conference Call on Fourth Quarter and Full Year 2024 Resul... at gurufocus.com
21st of February 2025
Market Concerns Put Pressure on Legend Biotech Corporation Shares at finance.yahoo.com
13th of February 2025
Arcutis Biotherapeutics Surges 15.9 percent Is This an Indication of Further Gains at zacks.com
6th of February 2025
Analysts Set Legend Biotech Co. PT at 79.50 - MarketBeat at news.google.com
24th of January 2025
Strength Seen in Eton Pharmaceuticals Can Its 10.8 percent Jump Turn into More Strength at zacks.com
13th of January 2025
Legend Biotech Stock Price Down 9.3 percent - Heres What Happened - MarketBeat at news.google.com
Legend Biotech Investors Sentiment
The influence of Legend Biotech's investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Legend. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to Legend Biotech's public news can be used to forecast risks associated with an investment in Legend. The trend in average sentiment can be used to explain how an investor holding Legend can time the market purely based on public headlines and social activities around Legend Biotech Corp. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Legend Biotech's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Legend Biotech's and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Legend Biotech's news discussions. The higher the estimated score, the more favorable is the investor's outlook on Legend Biotech.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Legend Biotech in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Legend Biotech's short interest history, or implied volatility extrapolated from Legend Biotech options trading.
Check out Legend Biotech Backtesting and Legend Biotech Hype Analysis. You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Legend Biotech. If investors know Legend will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Legend Biotech listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.96) | Revenue Per Share | Quarterly Revenue Growth 1.347 | Return On Assets | Return On Equity |
The market value of Legend Biotech Corp is measured differently than its book value, which is the value of Legend that is recorded on the company's balance sheet. Investors also form their own opinion of Legend Biotech's value that differs from its market value or its book value, called intrinsic value, which is Legend Biotech's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Legend Biotech's market value can be influenced by many factors that don't directly affect Legend Biotech's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Legend Biotech's value and its price as these two are different measures arrived at by different means. Investors typically determine if Legend Biotech is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Legend Biotech's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.